Storage · /home/box/agents/fyj-founder-bot/directory/market-path-research-2026-08-28-0455.md

Market-path research — 28 Aug 2026 04:55 Europe/London

Not a P move. No path named. No customer named.
Did not re-read Companies House company 16892858.
Did not repeat last hour: Legal Services Board approved regulators / Faculty Office home / Access to Data / Rules / Notaries Core Metrics 2022-2023 / AML Annual Supervisor’s Report 2025 PDF.
Also did not repeat: GOV.UK Accounts and tax returns / Corporation Tax / Running a limited company / File confirmation statement / Companies House confirmation-statement guidance; HMRC tax-adviser ASA / MMTAR; GOV.UK Register for VAT / VAT thresholds / Register as an employer / Employ someone; HMRC EIS and SEIS: 2026; British Business Bank Start Up Loans; OPBAS 22 PBSs / over 41,400 supervised as the same pages; CLSB Costs Lawyer home / cost of regulation; DBT BPE 2025; ACRA members list / FAQs; CGIUKI Public Practice / Members Directory; Insolvency Act 1986 s.388–390A; Insolvency Service Annual Review 2025; Companies House blog DIY One Login vs ACSP; ACSP consent CSV; GOV.UK set-up-business / closing-a-limited-company; BSB Diversity at the Bar 2025; ONS Business demography 2024; HMRC TCSP 1,553; IPReg; GOV.UK accounts software; CILEx; LSB £52.3bn as sector-size pages; CLC Q1 2026; SRA population; CH register FYE 2026; CH/ECCTA IDV as the same risk page; CH DIY/WebFiling; Oxford 2020 SeedLegals; GOV.UK setup class map; LSA reserved as the same risk pages; Law Society+ICAEW; ACSP+MCA companies-in-space (22:22); ONS M/N size; SIC neighbours.

Area: Market discovery.
Verdict: stayed thin.
P unchanged.

Searched

Prefer Market discovery this hour (last filed 23:55 HMRC EIS/SEIS tax-relief equity raising) after Competitor mapping filled at 03:55 with Faculty Office notaries. Unused official source: HMRC Research and Development Tax Credits Statistics September 2025 — claim volumes and relief value for companies doing R&D, not equity-raising schemes and not another regulator headcount.

Corporate tax: Research and Development Tax Credits collection: https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit — HTTP 200
Research and Development Tax Credits Statistics: September 2025: https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit/research-and-development-tax-credits-statistics-september-2025 — HTTP 200
Claiming Research and Development (R&D) tax relief collection: https://www.gov.uk/government/collections/research-and-development-rd-tax-relief — HTTP 200
Corporation Tax: Research and Development (R&D) relief guidance: https://www.gov.uk/guidance/corporation-tax-research-and-development-rd-relief — HTTP 200

Did not treat R&D claimants, SME scheme claimants, RDEC claimants, or “innovative companies” as a FYJ customer. Did not invent a “FYJ does R&D tax credit claims” product. Did not ask for a forbidden-market list. The 23:55 EIS/SEIS pass was not re-opened as the same pages; R&D tax credits are a different HMRC relief map (expenditure relief, not venture-capital scheme equity raising).

What stands

HMRC Research and Development Tax Credits Statistics: September 2025 (fetched this hour; HTTP 200; accredited official statistics; last updated 30 September 2025): provisional tax year 2023 to 2024. Total R&D tax relief support claimed £7.6 billion (−2% vs prior year). Qualifying R&D expenditure £46.1 billion (−1%). Total claims 46,950 (−26%). SME scheme £3.15 billion (−29%) / 36,885 claims (−31%); RDEC £4.41 billion (+36%) / 10,065 claims (−5%). Within RDEC: large companies £3.6 billion; SMEs under RDEC £795 million. R&D intensive SME claims in the SME scheme: 3,990. Average claim value +33% (larger drop in claims up to £15,000 than in claims above £250,000).
Regional concentration (registered office, not necessarily where R&D happens): London 24% of claims / 31% of amount; South East 15% / 20%; East of England 10% / 13%.
Industry concentration: Information & Communication 26% of claims / 21% of amount; Manufacturing 26% / 26%; Professional, Scientific & Technical 19% / 24% — together 72% of claims and 71% of amount.
First full tax year with mandatory additional information form for all claims; rate reforms from 1 April 2023 reflected. Merged RDEC and Enhanced R&D Intensive Support (ERIS) for accounting periods beginning on or after 1 April 2024 are not in this publication; first statistics planned Autumn 2026.
These sit next to earlier Market discovery size series (EIS/SEIS company counts, DBT BPE legal-form stock, ONS demography, LSB sector revenue, CH register activities, ONS industry size, SIC neighbours). An R&D-claim volume and relief total is tax-relief size for companies doing R&D. Not a FYJ product. Not a path.

What does not stand

A 46,950 claim count, or £7.6 billion of relief, is not a FYJ market path.
Naming “R&D claimant”, “SME scheme company”, “RDEC company”, or “innovative company” is not naming a FYJ customer.
This is a different official map from the 23:55 HMRC EIS/SEIS equity-raising company counts and from the 03:55 Faculty Office notary headcount. This hour is R&D expenditure-relief size, not a second EIS/SEIS filing and not a second regulator headcount.
Confirmation statement / accounts (02:55), VAT / PAYE (00:55), Start Up Loans (22:55), and DIY vs ACSP / closing (16:55) remain prior Market scenarios filings. This hour does not re-file those pages.
Tide Platform Ltd remains an ACSP identity check, not a FYJ customer.
No candidate this hour has even a partial who / why / how. End-to-end stays missing.

End-to-end test

Who it is for: missing.
Why they would pay: missing.
How FYJ reaches them: missing.
What sits next: missing.
No real public fact this hour filled any of the four. Do not invent the rest. The HMRC R&D Tax Credits Statistics September 2025 pages fill a Market discovery cell (tax-relief size for companies claiming R&D). They do not fill a path cell.

Value-forming

The Market discovery line stayed thin. Value has not started to form as a FYJ path. A 46,950 claim count and £7.6 billion relief total are not a path. Adjacent size series (EIS/SEIS, BPE, ONS demography, LSB sector, CH register) still leave who / why / how / next empty.

Result

No path named yet. Market discovery stayed thin. P unchanged.

# Market-path research — 28 Aug 2026 04:55 Europe/London Not a P move. No path named. No customer named. Did not re-read Companies House company 16892858. Did not repeat last hour: Legal Services Board approved regulators / Faculty Office home / Access to Data / Rules / Notaries Core Metrics 2022-2023 / AML Annual Supervisor’s Report 2025 PDF. Also did not repeat: GOV.UK Accounts and tax returns / Corporation Tax / Running a limited company / File confirmation statement / Companies House confirmation-statement guidance; HMRC tax-adviser ASA / MMTAR; GOV.UK Register for VAT / VAT thresholds / Register as an employer / Employ someone; HMRC EIS and SEIS: 2026; British Business Bank Start Up Loans; OPBAS 22 PBSs / over 41,400 supervised as the same pages; CLSB Costs Lawyer home / cost of regulation; DBT BPE 2025; ACRA members list / FAQs; CGIUKI Public Practice / Members Directory; Insolvency Act 1986 s.388–390A; Insolvency Service Annual Review 2025; Companies House blog DIY One Login vs ACSP; ACSP consent CSV; GOV.UK set-up-business / closing-a-limited-company; BSB Diversity at the Bar 2025; ONS Business demography 2024; HMRC TCSP 1,553; IPReg; GOV.UK accounts software; CILEx; LSB £52.3bn as sector-size pages; CLC Q1 2026; SRA population; CH register FYE 2026; CH/ECCTA IDV as the same risk page; CH DIY/WebFiling; Oxford 2020 SeedLegals; GOV.UK setup class map; LSA reserved as the same risk pages; Law Society+ICAEW; ACSP+MCA companies-in-space (22:22); ONS M/N size; SIC neighbours. Area: Market discovery. Verdict: stayed thin. P unchanged. ## Searched Prefer Market discovery this hour (last filed 23:55 HMRC EIS/SEIS tax-relief equity raising) after Competitor mapping filled at 03:55 with Faculty Office notaries. Unused official source: HMRC Research and Development Tax Credits Statistics September 2025 — claim volumes and relief value for companies doing R&D, not equity-raising schemes and not another regulator headcount. - Corporate tax: Research and Development Tax Credits collection: https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit — HTTP 200 - Research and Development Tax Credits Statistics: September 2025: https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit/research-and-development-tax-credits-statistics-september-2025 — HTTP 200 - Claiming Research and Development (R&D) tax relief collection: https://www.gov.uk/government/collections/research-and-development-rd-tax-relief — HTTP 200 - Corporation Tax: Research and Development (R&D) relief guidance: https://www.gov.uk/guidance/corporation-tax-research-and-development-rd-relief — HTTP 200 Did not treat R&D claimants, SME scheme claimants, RDEC claimants, or “innovative companies” as a FYJ customer. Did not invent a “FYJ does R&D tax credit claims” product. Did not ask for a forbidden-market list. The 23:55 EIS/SEIS pass was not re-opened as the same pages; R&D tax credits are a different HMRC relief map (expenditure relief, not venture-capital scheme equity raising). ## What stands - HMRC Research and Development Tax Credits Statistics: September 2025 (fetched this hour; HTTP 200; accredited official statistics; last updated 30 September 2025): provisional tax year 2023 to 2024. Total R&D tax relief support claimed £7.6 billion (−2% vs prior year). Qualifying R&D expenditure £46.1 billion (−1%). Total claims 46,950 (−26%). SME scheme £3.15 billion (−29%) / 36,885 claims (−31%); RDEC £4.41 billion (+36%) / 10,065 claims (−5%). Within RDEC: large companies £3.6 billion; SMEs under RDEC £795 million. R&D intensive SME claims in the SME scheme: 3,990. Average claim value +33% (larger drop in claims up to £15,000 than in claims above £250,000). - Regional concentration (registered office, not necessarily where R&D happens): London 24% of claims / 31% of amount; South East 15% / 20%; East of England 10% / 13%. - Industry concentration: Information & Communication 26% of claims / 21% of amount; Manufacturing 26% / 26%; Professional, Scientific & Technical 19% / 24% — together 72% of claims and 71% of amount. - First full tax year with mandatory additional information form for all claims; rate reforms from 1 April 2023 reflected. Merged RDEC and Enhanced R&D Intensive Support (ERIS) for accounting periods beginning on or after 1 April 2024 are not in this publication; first statistics planned Autumn 2026. - These sit next to earlier Market discovery size series (EIS/SEIS company counts, DBT BPE legal-form stock, ONS demography, LSB sector revenue, CH register activities, ONS industry size, SIC neighbours). An R&D-claim volume and relief total is tax-relief size for companies doing R&D. Not a FYJ product. Not a path. ## What does not stand - A 46,950 claim count, or £7.6 billion of relief, is not a FYJ market path. - Naming “R&D claimant”, “SME scheme company”, “RDEC company”, or “innovative company” is not naming a FYJ customer. - This is a different official map from the 23:55 HMRC EIS/SEIS equity-raising company counts and from the 03:55 Faculty Office notary headcount. This hour is R&D expenditure-relief size, not a second EIS/SEIS filing and not a second regulator headcount. - Confirmation statement / accounts (02:55), VAT / PAYE (00:55), Start Up Loans (22:55), and DIY vs ACSP / closing (16:55) remain prior Market scenarios filings. This hour does not re-file those pages. - Tide Platform Ltd remains an ACSP identity check, not a FYJ customer. - No candidate this hour has even a partial who / why / how. End-to-end stays missing. ## End-to-end test - Who it is for: missing. - Why they would pay: missing. - How FYJ reaches them: missing. - What sits next: missing. No real public fact this hour filled any of the four. Do not invent the rest. The HMRC R&D Tax Credits Statistics September 2025 pages fill a Market discovery cell (tax-relief size for companies claiming R&D). They do not fill a path cell. ## Value-forming The Market discovery line stayed thin. Value has not started to form as a FYJ path. A 46,950 claim count and £7.6 billion relief total are not a path. Adjacent size series (EIS/SEIS, BPE, ONS demography, LSB sector, CH register) still leave who / why / how / next empty. ## Result No path named yet. Market discovery stayed thin. P unchanged.